Patient management of long-term continuous subcutaneous insulin infusion

Journal of Advanced Nursing

Volumn 51, Issue 2, 2005, Pages 112-118

  Johansson, Unn Britt ^a   Adamson, Ulf ^a   Lins, Per Eric ^a   Wredling, Regina ^a  

^a DANDERYD HOSPITAL   (Sweden)

Author keywords

Advanced nursing practice; Continuous subcutaneous insulin infusion; Diabetes care; Practice evaluation; Type 1 diabetes

Indexed keywords

ANTIDIABETIC AGENT; DRUG DERIVATIVE; INSULIN; INSULIN LISPRO;

ADULT; AGED; ARTICLE; CROSS-SECTIONAL STUDY; EQUIPMENT; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; LONG TERM CARE; MALE; MIDDLE AGED; NURSING; SELF CARE; TIME;

ADULT; AGED; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; EQUIPMENT FAILURE; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; LONG-TERM CARE; MALE; MIDDLE AGED; SELF CARE; TIME FACTORS;

EID: 22144457111     PISSN: 03092402     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2648.2005.03475.x     Document Type: Article

References (23)

1. Adamson U., Lins P.E. & Atvall S. (2000) Insulinpumpbehandling hos vuxna. Kliniska riktlinjer. Diabetolog Nytt 3, 82-84.
2. American Association of Diabetes Educators (2003) Education for continuous subcutaneous insulin infusion pump users. The Diabetes Educator 29, 97-99.
3. American Diabetes Association (2003) Continuous subcutaneous insulin infusion. Diabetes Care 26, 125.
4. Bode B.W. & Strange P. (2001) Efficacy, safety, and pump compatibility of insulin aspart used in continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes. Diabetes Care 24, 69-72.
5. Bode B.W., Sabbah H.T., Gross T.M., Fredrickson L.P. & Davidson P.C. (2002a) Diabetes management in the new millennium using insulin pump therapy. Diabetes/metabolism Research and Reviews 18, 14-20.
6. Bode B., Weinstein R., Bell D., McGill J., Nadeau D., Raskin P., Davidson J., Henry R., Huang W.C. & Reinhardt R.R. (2002b) Comparison of insulin as part with buffered regular insulin and insulin lispro in continuous subcutaneous insulin infusion: a randomized study in type 1 diabetes. Diabetes Care 25, 439-444.
7. Colquitt J., Royle P. & Waugh N. (2003) Are analogue insulins better than soluble in continuous subcutaneous insulin infusion? Results of a meta-analysis. Diabetic Medicine 20, 863-866.
8. Deeb L.C. & Williams P.E. (1986) Surveillance in Florida of continuous subcutaneous insulin infusion use in cohort. Diabetes Care 9, 591-595.
9. Demirdjian S., Bardin C., Savin S., Zirinis P., Chast F., Slama G. & Selam J.L. (1998) Lispro insulin is suitable for external pumps but not for implantable pumps. Diabetes Care 21, 867-868.
10. Guinn T.S., Bailey G.J. & Mecklenburg R.S. (1988) Factors related to discontinuation of continuous subcutaneous insulin-infusion therapy. Diabetes Care 11, 46-51.
11. Johansson U.B., Adamson U.C., Lins P.E. & Wredling R.A. (2000) Improved blood glucose variability, HbA1c and less insulin requirement in IDDM patients using insulin lispro in CSII. The Swedish multicenter lispro insulin study. Diabetes and Metabolism 26, 192-196.
12. Leichter S.B., Schreiner M.E., Reynolds L.R. & Bolick T. (1985) Long-term follow-up of diabetic patients using insulin infusion pumps. Considerations for future clinical application. Archives of Internal Medicine 145, 1409-1412.
13. Melki V., Renard E., Lassmann-Vague V., Boivin S., Guerci B., Hanaire-Broutin H., Bringer J., Belicar P., Jeandidier N., Meyer L., Blin P., Augendre-Ferrante B. & Tauber J.P. (1998) Improvement of HbA1c and blood glucose stability in IDDM patients treated with lispro insulin analog in external pumps. Diabetes Care 21, 977-982.
14. Pickup J. & Keen H. (2002) Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes. Diabetes Care 25, 593-598.
15. Renner R., Pfutzner A., Trautmann M., Harzer O., Sauter K. & Landgraf R. (1999) Use of insulin lispro in continuous subcutaneous insulin infusion treatment. Results of a multicenter trial. German Humalog-CSII Study Group. Diabetes Care 22, 784-788.
16. Schmauss S., Konig A. & Landgraf R. (1998) Human insulin analogue [LYS(B28), PRO(B29)]: the ideal pump insulin? Diabetic Medicine 15, 247-249.
17. Strowig S. (1993) Initiation and management of insulin pump therapy. The Diabetes Educator 19, 50-59.
18. The DCCT Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The New England Journal of Medicine 329, 977-986.
19. Tsui E., Barnie A., Ross S., Parkes R. & Zinman B. (2001) Intensive insulin therapy with insulin lispro: a randomized trial of continuous subcutaneous insulin infusion versus multiple daily insulin injection. Diabetes Care 24, 1722-1727.
20. Wolpert H.A., Faradji R.N., Bonner-Weir S. & Lipes M.A. (2002) Metabolic decompensation in pump users due to lispro insulin precipitation. British Medical Journal 321, 1253.
21. Wredling R., Lins P.E. & Adamson U. (1993) Factors influencing the clinical outcome of continuous subcutaneous insulin infusion in routine practice. Diabetes Research and Clinical Practice 19, 59-67.
22. Wright A.W. & Little J.A. (1998) Cannula occlusion with use of insulin lispro and insulin infusion system. Diabetes Care 21, 874-875.
23. Zinman B., Tildesley H., Chiasson J.L., Tsui E. & Strack T. (1997) Insulin lispro in CSII: results of a double-blind cross-over study. Diabetes 46, 440-443.